UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.140

Sortiert nach

HIV-1 Nef Blocks Transport of MHC Class I Molecules to the Cell Surface Via a PI 3-Kinase-Dependent Pathway

Virology (New York, N.Y.), 2001-04, Vol.282 (2), p.267-277

2001

Volltextzugriff (PDF)

TELEMAM: A cluster randomised trial to assess the use of telemedicine in multi-disciplinary breast cancer decision making

European journal of cancer (1990), 2007-11, Vol.43 (17), p.2506-2514

2007

Volltextzugriff (PDF)

Future deforestation in the Amazon and consequences for South American climate

Agricultural and forest meteorology, 2015-12, Vol.214-215, p.12-24

2015

Volltextzugriff (PDF)

Treatment of bipolar depression with carbamazepine: Results of an open study

Biological psychiatry (1969), 1996-11, Vol.40 (9), p.935-937

1996

Volltextzugriff (PDF)

Film thickness distribution in magnetron sputtering

Vacuum, 1988, Vol.38 (8), p.791-794

Swann, S

1988

Volltextzugriff (PDF)

Maize yield under a changing climate: The hidden role of vapor pressure deficit

Agricultural and forest meteorology, 2019-12, Vol.279 (C), p.107692, Article 107692

2019

Volltextzugriff (PDF)

Long COVID in Children and Young after Infection or Reinfection with the Omicron Variant: A Prospective Observational Study

The Journal of pediatrics, 2023-08, Vol.259, p.113463, Article 113463

2023

Volltextzugriff (PDF)

49

International journal of radiation oncology, biology, physics, 2006-11, Vol.66 (3), p.S28-S29

2006

Volltextzugriff (PDF)

49: Comparison of 5-Year Survival Between RTOG-94-10 and a Phase 2 Study of Induction Chemotherapy Followed by Efaproxiral + Radiotherapy in Patients With Locally Advanced NSCLC

International journal of radiation oncology, biology, physics, 2006, Vol.66 (3), p.S28-S29

2006

Volltextzugriff (PDF)

A Phase I Trial of Gemcitabine, Carboplatin or Gemcitabine, Paclitaxel and Concurrent Radiation Therapy Followed by Consolidative Gemcitabine and Carboplatin for Inoperable Stage III Non-Small Cell Lung Cancer: An RTOG 0017 Study

International journal of radiation oncology, biology, physics, 2005-10, Vol.63, p.S42-S43

2005

Volltextzugriff (PDF)

Gender Differences in Demographic and Health Characteristics of the Million Veteran Program Cohort

Women's health issues, 2019-06, Vol.29 (Suppl 1), p.S56-S66

2019

Volltextzugriff (PDF)

Alcohol Consumption and Risk of Coronary Artery Disease (from the Million Veteran Program)

The American journal of cardiology, 2018-05, Vol.121 (10), p.1162-1168

2018

Volltextzugriff (PDF)

109

International journal of radiation oncology, biology, physics, 2006-11, Vol.66 (3), p.S62

2006

Volltextzugriff (PDF)

2595

International journal of radiation oncology, biology, physics, 2006-11, Vol.66 (3), p.S541

2006

Volltextzugriff (PDF)

Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non–small-cell lung carcinoma: Analysis of the Radiation Therapy Oncology Group (RTOG) experience

International journal of radiation oncology, biology, physics, 2005-11, Vol.63 (3), p.667-671

2005

Volltextzugriff (PDF)

Higher BED is Associated with Improved Local-regional Control and Survival for NSCLC Treated with Chemoradiotherapy: An RTOG Analysis

International journal of radiation oncology, biology, physics, 2005-10, Vol.63, p.S40-S40

2005

Volltextzugriff (PDF)

Reassessing Prognostic Factors in the Era of Combined Modality Therapy for Locally Advanced NSCLC: A Retrospective Analysis of RTOG 9410 and 9801

International journal of radiation oncology, biology, physics, 2005-10, Vol.63, p.S39-S40

2005

Volltextzugriff (PDF)

A Phase II Study of Cetuximab (C225) in Combination with Chemoradiation (CRT) in Patients (PTS) with Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC): An Interim Overall Toxicity Report of the RTOG 0324 Trial

International journal of radiation oncology, biology, physics, 2005-10, Vol.63, p.S44-S44

2005

Volltextzugriff (PDF)

PD-121 Increasing tumor volume is predictive of poor overall- andprogression free survival: Secondary analysis of the Radiation Therapy Oncology Group (RTOG) 93-11 Phase I–II radiation dose escalation study in patients with inoperable non-small cell lung cancer (NSCLC)

Lung cancer (Amsterdam, Netherlands), 2005-07, Vol.49, p.S102-S102

2005

Volltextzugriff (PDF)

P-578 A phase I trial of gemcitabine, carboplatin or gemcitabine paclitaxel and concurrent radiation therapy followed by consolidative gemcitabine and carboplatin for inoperable stage III non-small cell lung cancer: An RTOG study

Lung cancer (Amsterdam, Netherlands), 2005-07, Vol.49, p.S270-S270

2005

Volltextzugriff (PDF)

O-042 Overall treatment time during concurrent chemoradiotherapy and outcomes: An RTOG secondary analysis

Lung cancer (Amsterdam, Netherlands), 2005-07, Vol.49, p.S17-S17

2005

Volltextzugriff (PDF)

PD-074 Does response rate in the induction chemotherapy predictsurvival for locally advanced non-small cell lung cancer (LANSCLC)?: Secondary analysis of RTOG 8804/8808

Lung cancer (Amsterdam, Netherlands), 2005-07, Vol.49, p.S88-S88

2005

Volltextzugriff (PDF)

109: Sociodemographic Factors Are Significant Predictors of Toxicity in RTOG Non-Operative NSCLC Trials

International journal of radiation oncology, biology, physics, 2006, Vol.66 (3), p.S62-S62

2006

Volltextzugriff (PDF)

2595: Is There a “Disconnect” Between Physician and Patient- Reported Outcomes (PROs): An Analysis of RTOG 98–01

International journal of radiation oncology, biology, physics, 2006, Vol.66 (3), p.S541-S541

2006

Volltextzugriff (PDF)

Back to B.E.D. Predictors of Outcome in RTOG Non-Operative Non-Small Cell Lung Cancer (NSCLC) Trials

International journal of radiation oncology, biology, physics, 2005-10, Vol.63, p.S230-S231

2005

Volltextzugriff (PDF)

1 – 25 von 1.140

Suche als RSS-Feed

Aktive Filter

SpracheKatalanisch

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.101)
Mit Volltextzugriff
(1.131)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(648)
Life Sciences & Biomedicine
(458)
Humans
(240)
Male
(226)
Animals
(217)
Biological And Medical Sciences
(214)
Female
(162)
Physical Sciences
(146)
Medical Sciences
(143)
Neurosciences & Neurology
(143)
Adult
(113)
Rats
(113)
Neurosciences
(110)
Psychology. Psychoanalysis. Psychiatry
(86)
Social Sciences
(85)
Fundamental And Applied Biological Sciences. Psychology
(80)
Middle Aged
(70)
Technology
(70)
Psychiatry
(68)
Science & Technology - Other Topics
(66)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

HIV-1 Nef Blocks Transport of MHC Class I Molecules to the Cell Surface Via a PI 3-Kinase-Dependent Pathway

TELEMAM: A cluster randomised trial to assess the use of telemedicine in multi-disciplinary breast cancer decision making

Future deforestation in the Amazon and consequences for South American climate

Treatment of bipolar depression with carbamazepine: Results of an open study

Film thickness distribution in magnetron sputtering

Maize yield under a changing climate: The hidden role of vapor pressure deficit

Long COVID in Children and Young after Infection or Reinfection with the Omicron Variant: A Prospective Observational Study

49

49: Comparison of 5-Year Survival Between RTOG-94-10 and a Phase 2 Study of Induction Chemotherapy Followed by Efaproxiral + Radiotherapy in Patients With Locally Advanced NSCLC

A Phase I Trial of Gemcitabine, Carboplatin or Gemcitabine, Paclitaxel and Concurrent Radiation Therapy Followed by Consolidative Gemcitabine and Carboplatin for Inoperable Stage III Non-Small Cell Lung Cancer: An RTOG 0017 Study

Gender Differences in Demographic and Health Characteristics of the Million Veteran Program Cohort

Alcohol Consumption and Risk of Coronary Artery Disease (from the Million Veteran Program)

109

2595

Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non–small-cell lung carcinoma: Analysis of the Radiation Therapy Oncology Group (RTOG) experience

Higher BED is Associated with Improved Local-regional Control and Survival for NSCLC Treated with Chemoradiotherapy: An RTOG Analysis

Reassessing Prognostic Factors in the Era of Combined Modality Therapy for Locally Advanced NSCLC: A Retrospective Analysis of RTOG 9410 and 9801

A Phase II Study of Cetuximab (C225) in Combination with Chemoradiation (CRT) in Patients (PTS) with Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC): An Interim Overall Toxicity Report of the RTOG 0324 Trial

PD-121 Increasing tumor volume is predictive of poor overall- andprogression free survival: Secondary analysis of the Radiation Therapy Oncology Group (RTOG) 93-11 Phase I–II radiation dose escalation study in patients with inoperable non-small cell lung cancer (NSCLC)

P-578 A phase I trial of gemcitabine, carboplatin or gemcitabine paclitaxel and concurrent radiation therapy followed by consolidative gemcitabine and carboplatin for inoperable stage III non-small cell lung cancer: An RTOG study

O-042 Overall treatment time during concurrent chemoradiotherapy and outcomes: An RTOG secondary analysis

PD-074 Does response rate in the induction chemotherapy predictsurvival for locally advanced non-small cell lung cancer (LANSCLC)?: Secondary analysis of RTOG 8804/8808

109: Sociodemographic Factors Are Significant Predictors of Toxicity in RTOG Non-Operative NSCLC Trials

2595: Is There a “Disconnect” Between Physician and Patient- Reported Outcomes (PROs): An Analysis of RTOG 98–01

Back to B.E.D. Predictors of Outcome in RTOG Non-Operative Non-Small Cell Lung Cancer (NSCLC) Trials

Aktive Filter

Suchergebnisse filtern